S. Haney

发表

Peak emission wavelength and fluorescence lifetime are coupled in far-red, GFP-like fluorescent proteins

D. Andrews, Laura Canty, S. Hariharan, 2018, PloS one.

Biologically Relevant Heterogeneity: Metrics and Practical Insights

Chakra Chennubhotla, Albert Gough, Mark E Schurdak, 2017, SLAS discovery : advancing life sciences R & D.

High-Content Screening Approaches That Minimize Confounding Factors in RNAi, CRISPR, and Small Molecule Screening.

S. Haney, 2018, Methods in molecular biology.

Increasing the robustness and validity of RNAi screens.

S. Haney, 2007, Pharmacogenomics.

High-content screening moves to the front of the line.

Jing Zhang, Jing Pan, Peter LaPan, 2006, Drug discovery today.

Discovery of novel inhibitors of the ZipA/FtsZ complex by NMR fragment screening coupled with structure-based design.

Ramaswamy Nilakantan, Russell G Dushin, Désirée H H Tsao, 2006, Bioorganic & medicinal chemistry.

Expanding the repertoire of RNA interference screens for developing new anticancer drug targets

S. Haney, 2007, Expert opinion on therapeutic targets.

Fluorescence and Cell Labeling

S. Haney, Anthony Davies, 2015 .

Solar flair.

M. Stampfer, J. Garbe, Jee Hyung Lee, 2003, Molecular Cancer.

RNA Interference Technology: RNAi and the drug discovery process

S. Haney, P. LaPan, P. Yaworsky, 2005 .

Quantitative optimization of reverse transfection conditions for 384-well siRNA library screening.

S. Haney, P. LaPan, Jing Zhang, 2008, Assay and drug development technologies.

Anticancer drug development incorporating high-content screening and RNAi: synergistic approaches to improve target identification and validation

S. Haney, 2006, Expert opinion on drug discovery.

Combinatorial synthesis of substituted 3-(2-indolyl)piperidines and 2-phenyl indoles as inhibitors of ZipA-FtsZ interaction.

T. Rush, L. Mosyak, S. Haney, 2004, Bioorganic & medicinal chemistry.

The bacterial cell‐division protein ZipA and its interaction with an FtsZ fragment revealed by X‐ray crystallography

Yan Zhang, L. Mosyak, W. Somers, 2001, The EMBO journal.

Transcription Profiling-Based Identification ofStaphylococcus aureus Genes Regulated by the agrand/or sarA Loci

R. Zagursky, G. Tucker-Kellogg, S. Haney, 2001, Journal of bacteriology.

siRNA Off-Target Effects Can Be Reduced at Concentrations That Match Their Individual Potency

Daniel R. Caffrey, J. Hughes, A. Seymour, 2011, PloS one.

Monoclonal Antibodies to Benzodiazepines

S. Haney, L. Sangameswaran, Dongeun Park, 1985, Journal of neurochemistry.

Single cell cytometry of protein function in RNAi treated cells and in native populations

Jing Zhang, Jing Pan, Peter LaPan, 2007 .

Image-Based Assessment of Growth and Signaling Changes in Cancer Cells Mediated by Direct Cell-Cell Contact

A. Hill, R. Martinez, S. Haney, 2009, PloS one.

Analyzing Well‐Level Data

Steven A. Haney, S. Haney, 2015 .

A Kinome-Wide siRNA Screen Identifies Multiple Roles for Protein Kinases in Hypoxic Stress Adaptation, Including Roles for IRAK4 and GAK in Protection against Apoptosis in VHL−/− Renal Carcinoma Cells, Despite Activation of the NF-κB Pathway

A. Hill, S. Haney, P. LaPan, 2013, Journal of biomolecular screening.

Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental Results

Steven A Haney, S. Haney, 2014, Journal of biomolecular screening.

Increased retention of functional fusions to toxic genes in new two-hybrid libraries of the E. coli strain MG1655 and B. subtilis strain 168 genomes, prepared without passaging through E. coli

S. Haney, S. Projan, D. Keeney, 2003, BMC Genomics.

RNAi Screening in Primary Human Hepatocytes of Genes Implicated in Genome-Wide Association Studies for Roles in Type 2 Diabetes Identifies Roles for CAMK1D and CDKAL1, among Others, in Hepatic Glucose Regulation

L. Guey, S. Haney, Juan Zhao, 2013, PloS one.

An introduction to high content screening : imaging technology, assay development, and data analysis in biology and drug discovery

C. Shamu, S. Haney, A. Chakravarty, 2014 .

High content screening : science, techniques and applications

Steven A. Haney, S. Haney, 2008 .

Abstract 5245: Identification and characterization of the IDO1 inhibitor LY3381916

J. F. Schindler, M. Kalos, D. Clawson, 2018, Experimental and Molecular Therapeutics.

Impact of image segmentation on high-content screening data quality for SK-BR-3 cells

Peter LaPan, Andrew A. Hill, Yizheng Li, 2007, BMC Bioinformatics.

Genetic Analysis of the Escherichia coli FtsZ·ZipA Interaction in the Yeast Two-hybrid System

P. D. de Boer, S. Haney, D. Keeney, 2001, The Journal of Biological Chemistry.

Factoring and Clustering High Content Data

Steven A. Haney, S. Haney, 2015 .

Single cell cytometry of protein function in RNAi treated cells and in native populations

A. Hill, S. Haney, P. LaPan, 2008, BMC Cell Biology.

HCS in Cellular Oncology and Tumor Biology

S. Haney, P. LaPan, Jing Zhang, 2007 .

Analysis of Multiparametric HCS Data

A. Hill, S. Haney, P. LaPan, 2007 .

RNAi and high-content screening in target identification and validation.

Steven A Haney, S. Haney, 2005, IDrugs : the investigational drugs journal.

Analyzing Cell‐Level Data

Arijit Chakravarty, Steven A. Haney, Lin T. Guey, 2015 .

Rapid Assessment and Visualization of Normality in High-Content and Other Cell-Level Data and Its Impact on the Interpretation of Experimental Results

S. Haney, 2014, Journal of biomolecular screening.

Single cell cytometry of protein function in RNAi treated cells and in native populations

A. Hill, S. Haney, P. LaPan, 2008, BMC Cell Biology.

High content screening : science, techniques and applications

S. Haney, 2008 .

Genomics in anti-infective drug discovery--getting to endgame.

Ellen Murphy, Steven A Haney, S. Haney, 2002, Current pharmaceutical design.